NAFLD (Non-alcoholic Fatty Liver Disease)

Metabolic·MeSH: Fatty Liver

Prevalence

16356.2 / 100K

Incidence

630.8 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target NAFLD (Non-alcoholic Fatty Liver Disease)?

There are 1 clinical trial targeting NAFLD (Non-alcoholic Fatty Liver Disease) tracked by BioSniper.

What is the prevalence of NAFLD (Non-alcoholic Fatty Liver Disease)?

The estimated prevalence of NAFLD (Non-alcoholic Fatty Liver Disease) is approximately 16356.2 per 100,000 population.

Deep-dive into NAFLD (Non-alcoholic Fatty Liver Disease)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    NAFLD (Non-alcoholic Fatty Liver Disease) — Drugs in Development & Clinical Trials | BioSniper